CITIUS PHARMAC (Germany) Today
| 47N Stock | EUR 3.29 0.00 0.00% |
Performance0 of 100
| Odds Of DistressOver 67
|
CITIUS PHARMAC is trading at 3.29 as of the 15th of December 2024. This is a No Change since the beginning of the trading day. The stock's lowest day price was 3.29. CITIUS PHARMAC has more than 67 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. CITIUS PHARMAC has reported 25 for 1 split on 26th of November 2024. The performance scores are derived for the period starting the 15th of November 2024 and ending today, the 15th of December 2024. Click here to learn more.
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and commercializes critical care products targeting medical needs with a focus on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company has 146.21 M outstanding shares. More on CITIUS PHARMAC DL
Moving together with CITIUS Stock
Moving against CITIUS Stock
CITIUS Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. CITIUS PHARMAC's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding CITIUS PHARMAC or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
CITIUS PHARMAC DL (47N) is traded on Frankfurt Exchange in Germany and employs 21 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 186.2 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate CITIUS PHARMAC's market, we take the total number of its shares issued and multiply it by CITIUS PHARMAC's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. CITIUS PHARMAC DL classifies itself under Healthcare sector and is part of Biotechnology industry. The entity has 146.21 M outstanding shares.
CITIUS PHARMAC DL has accumulated about 115.66 M in cash with (22.02 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.79.
Check CITIUS PHARMAC Probability Of Bankruptcy
Ownership AllocationCITIUS PHARMAC holds a total of 146.21 Million outstanding shares. CITIUS PHARMAC DL shows 8.42 percent of its outstanding shares held by insiders and 11.0 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check CITIUS Ownership Details
CITIUS PHARMAC DL Risk Profiles
Although CITIUS PHARMAC's alpha and beta are two of the key measurements used to evaluate CITIUS PHARMAC's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 4.81 | |||
| Standard Deviation | 7.77 | |||
| Variance | 60.4 | |||
| Risk Adjusted Performance | (0.14) |
CITIUS Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in CITIUS PHARMAC without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run AI Portfolio Architect Now
AI Portfolio ArchitectUse AI to generate optimal portfolios and find profitable investment opportunities |
| All Next | Launch Module |
Other Information on Investing in CITIUS Stock
CITIUS PHARMAC financial ratios help investors to determine whether CITIUS Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CITIUS with respect to the benefits of owning CITIUS PHARMAC security.